News
PLX
2.480
-2.75%
-0.070
Weekly Report: what happened at PLX last week (1019-1023)?
Weekly Report · 1d ago
Weekly Report: what happened at PLX last week (1012-1016)?
Weekly Report · 10/19 09:33
Weekly Report: what happened at PLX last week (1005-1009)?
Weekly Report · 10/12 09:35
Weekly Report: what happened at PLX last week (0928-1002)?
Weekly Report · 10/05 09:35
Weekly Report: what happened at PLX last week (0921-0925)?
Weekly Report · 09/28 09:33
Netflix downgraded, SanDisk initiated: Wall Street’s top analyst calls
TipRanks · 09/22 13:45
Weekly Report: what happened at PLX last week (0914-0918)?
Weekly Report · 09/21 09:33
Weekly Report: what happened at PLX last week (0907-0911)?
Weekly Report · 09/14 09:35
Weekly Report: what happened at PLX last week (0831-0904)?
Weekly Report · 09/07 09:32
Weekly Report: what happened at PLX last week (0824-0828)?
Weekly Report · 08/31 09:35
Weekly Report: what happened at PLX last week (0817-0821)?
Weekly Report · 08/24 09:36
Protalix Biotherapeutics Earnings Call Signals Strong Momentum
TipRanks · 08/24 00:16
Weekly Report: what happened at PLX last week (0810-0814)?
Weekly Report · 08/17 09:36
Protalix BioTherapeutics GAAP EPS of $0.05 beats by $0.06, revenue of $19.8M beats by $6.87M
Seeking Alpha · 08/12 10:57
Protalix BioTherapeutics Q2 EPS $0.05 Misses $0.12 Estimate, Sales $19.896M Beat $12.931M Estimate
Benzinga · 08/12 10:51
Here are the major earnings before the open Wednesday
Seeking Alpha · 08/11 22:00
Protalix BioTherapeutics Q2 Earnings Preview
Seeking Alpha · 08/11 15:10
Weekly Report: what happened at PLX last week (0803-0807)?
Weekly Report · 08/10 09:34
Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026
PR Newswire · 08/05 10:50
Weekly Report: what happened at PLX last week (0727-0731)?
Weekly Report · 08/03 09:34
More
Webull provides a variety of real-time PLX stock news. You can receive the latest news about Protalix Biother through multiple platforms. This information may help you make smarter investment decisions.
About PLX
Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx. In addition, the Company is developing PEGylated uricase, or PRX-115, for the treatment of uncontrolled gout, Long Acting (LA) DNase I, or PRX-119, for the treatment of NETs-related diseases, and other technologies and preclinical assets. Its ProCellEx platform is being used to manufacture both of its approved and marketed products as well as PRX-115 and PRX-119. PRX-115, a plant cell-expressed recombinant PEGylated Uricase (urate oxidase) - a chemically modified enzyme to treat uncontrolled gout. PRX-119 is a plant cell-expressed PEGylated recombinant human DNase I product candidate. Its product includes Elelyso and Elfabrio. Elelyso is an enzyme replacement therapy (ERT) for the treatment of patients with Gaucher disease.